NCT04800497View on ClinicalTrials.gov

The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

February 7, 2026

Study Completion Date

February 7, 2026

Conditions
Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaCirculating Tumor Cell
Interventions
PROCEDURE

Hepatic resection

Hepatic resection for HCC

Trial Locations (4)

20900

RECRUITING

Ospedale San Gerardo, Monza

Unknown

RECRUITING

ASST Grande Ospedale Metropolitano Niguarda, Milan

RECRUITING

Università del Piemonte Orientale, Novara

NOT_YET_RECRUITING

Humanitas Research Hospital, Rozzano

Sponsors
All Listed Sponsors
collaborator

Università degli Studi del Piemonte Orientale Amedeo Avogadro

OTHER

collaborator

Niguarda Hospital

OTHER

collaborator

Humanitas Clinical and Research Center

OTHER

collaborator

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER

lead

University of Milano Bicocca

OTHER